178 related articles for article (PubMed ID: 17397496)
1. Galectin-3 and CD44v6 positivity by RT-PCR method in fine needle aspirates of benign thyroid lesions.
Matesa N; Samija I; Kusić Z
Cytopathology; 2007 Apr; 18(2):112-6. PubMed ID: 17397496
[TBL] [Abstract][Full Text] [Related]
2. Galectin-3 and CD44v6 as markers for preoperative diagnosis of thyroid cancer by RT-PCR.
Samija I; Mateša N; Lukač J; Kusić Z
Diagn Mol Pathol; 2011 Dec; 20(4):233-41. PubMed ID: 22089351
[TBL] [Abstract][Full Text] [Related]
3. Immunostaining of galectin-3 and CD44v6 using fine-needle aspiration for distinguishing follicular carcinoma from adenoma.
Maruta J; Hashimoto H; Yamashita H; Yamashita H; Noguchi S
Diagn Cytopathol; 2004 Dec; 31(6):392-6. PubMed ID: 15540177
[TBL] [Abstract][Full Text] [Related]
4. [Expression and clinical significance of galectin-3 in well-differentiated thyroid carcinoma].
Ouyang D; Chen FJ; Wei MW; Yang AK; Chen ZQ; Li QL; Chen YF
Ai Zheng; 2005 Nov; 24(11):1367-71. PubMed ID: 16552965
[TBL] [Abstract][Full Text] [Related]
5. Utility of galectin 3 expression in thyroid aspirates as a diagnostic marker in differentiating benign from malignant thyroid neoplasms.
Aron M; Kapila K; Verma K
Indian J Pathol Microbiol; 2006 Jul; 49(3):376-80. PubMed ID: 17001889
[TBL] [Abstract][Full Text] [Related]
6. Thyroid fine-needle aspiration samples inadequate for reverse transcriptase-polymerase chain reaction analysis.
Samija I; Matesa N; Lukac J; Kusic Z
Cancer; 2008 Jun; 114(3):187-95. PubMed ID: 18404696
[TBL] [Abstract][Full Text] [Related]
7. Accuracy of fine needle aspiration biopsy with and without the use of tumor markers in cytologically indeterminate thyroid lesions.
Matesa N; Samija I; Kusić Z
Coll Antropol; 2010 Mar; 34(1):53-7. PubMed ID: 20432733
[TBL] [Abstract][Full Text] [Related]
8. Galectin-3 and CD44v6 isoforms in the preoperative evaluation of thyroid nodules.
Gasbarri A; Martegani MP; Del Prete F; Lucante T; Natali PG; Bartolazzi A
J Clin Oncol; 1999 Nov; 17(11):3494-502. PubMed ID: 10550147
[TBL] [Abstract][Full Text] [Related]
9. Fine-needle aspiration biopsy-RT-PCR expression analysis of prothymosin alpha and parathymosin in thyroid: novel proliferation markers?
Letsas KP; Vartholomatos G; Tsepi C; Tsatsoulis A; Frangou-Lazaridis M
Neoplasma; 2007; 54(1):57-62. PubMed ID: 17203893
[TBL] [Abstract][Full Text] [Related]
10. Fine-needle aspiration biopsy of Hurthle cell lesions of the thyroid gland: A cytomorphologic study of 139 cases with statistical analysis.
Elliott DD; Pitman MB; Bloom L; Faquin WC
Cancer; 2006 Apr; 108(2):102-9. PubMed ID: 16453320
[TBL] [Abstract][Full Text] [Related]
11. Galectin-3 is not an universal marker of malignancy in thyroid nodular disease in children and adolescents.
Niedziela M; Maceluch J; Korman E
J Clin Endocrinol Metab; 2002 Sep; 87(9):4411-5. PubMed ID: 12213909
[TBL] [Abstract][Full Text] [Related]
12. Follicular thyroid lesions coexisting with Hashimoto's thyroiditis: incidence and possible sources of diagnostic errors.
Kollur SM; El Sayed S; El Hag IA
Diagn Cytopathol; 2003 Jan; 28(1):35-8. PubMed ID: 12508180
[TBL] [Abstract][Full Text] [Related]
13. [Detection of malignancy markers in thyroid nodules by reverse transcriptase polymerase chain reaction (RT-PCR)].
Pineda P; Rojas P; Liberman C; Moyano L; Goecke I
Rev Med Chil; 2003 Sep; 131(9):965-72. PubMed ID: 14635582
[TBL] [Abstract][Full Text] [Related]
14. Galectin-3 does not reliably distinguish benign from malignant thyroid neoplasms.
Mehrotra P; Okpokam A; Bouhaidar R; Johnson SJ; Wilson JA; Davies BR; Lennard TW
Histopathology; 2004 Nov; 45(5):493-500. PubMed ID: 15500653
[TBL] [Abstract][Full Text] [Related]
15. Assessment of cyclin D1 gene expression as a prognostic factor in benign and malignant thyroid lesions.
Brzeziańska E; Cyniak-Magierska A; Sporny S; Pastuszak-Lewandoska D; Lewiński A
Neuro Endocrinol Lett; 2007 Aug; 28(4):341-50. PubMed ID: 17693985
[TBL] [Abstract][Full Text] [Related]
16. Circulating tumor cells detected by reverse transcription-polymerase chain reaction for carcinoembryonic antigen mRNA: distinguishing follicular thyroid carcinoma from adenoma.
Sato T; Harao M; Nakano S; Jotsuka T; Suda N; Yamashita J
Surgery; 2005 May; 137(5):552-8. PubMed ID: 15855928
[TBL] [Abstract][Full Text] [Related]
17. [Significance of galectin-3 and CD44v6 expression in differential diagnosis of thyroid nodules].
Wang LH; Zhao YJ; Wang XY; Yuan P; Xu WQ; Xiao JC; Xu JP; Luo BR
Zhonghua Zhong Liu Za Zhi; 2005 Sep; 27(9):547-50. PubMed ID: 16438854
[TBL] [Abstract][Full Text] [Related]
18. HMGA2 expression analysis in cytological and paraffin-embedded tissue specimens of thyroid tumors by relative quantitative RT-PCR.
Jin L; Lloyd RV; Nassar A; Lappinga PJ; Sebo TJ; Swartz K; Seys AR; Erickson-Johnson MR; Roth CW; Evers BR; Oliveira AM; Zhang J
Diagn Mol Pathol; 2011 Jun; 20(2):71-80. PubMed ID: 21532495
[TBL] [Abstract][Full Text] [Related]
19. Cytoplasmic colloid inclusions in thyroid lesions: a cytomorphological study based on fine needle aspiration.
Das DK; Pathan SK; Francis IM; Sheikh ZA; Al-Juwaiser A; Shaheen A; Prabha K; George J; Kapila K
Cytopathology; 2005 Oct; 16(5):233-9. PubMed ID: 16181309
[TBL] [Abstract][Full Text] [Related]
20. The meaning and predictivity of Hürthle cells in fine needle aspiration cytology for thyroid nodular disease.
Kauffmann PR; Dejax C; de Latour M; Dauplat J
Eur J Surg Oncol; 2004 Sep; 30(7):786-9. PubMed ID: 15296995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]